[{"NetIncomeLoss_4_FY_USD":-110715000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_4_FY_USD":300000.0,"InterestPaidNet_4_FY_USD":267000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":-8000.0,"EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_4_FY_pure":0.002,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_FY_USD":9600000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-50481000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":-17200000.0,"PaymentsForProceedsFromOtherInvestingActivities_4_FY_USD":3000.0,"AssetsCurrent_0_FY_USD":129611000.0,"OtherNoncashIncomeExpense_4_FY_USD":-35000.0,"RestructuringCharges_4_FY_USD":300000.0,"AdjustmentsToAdditionalPaidInCapitalStockSplit_4_FY_USD":47000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":22622000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":28099000.0,"ResearchAndDevelopmentInProcess_4_FY_USD":69861000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":29000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_4_FY_pure":-0.129,"CommonStockSharesIssued_0_FY_shares":4231135.0,"Assets_0_FY_USD":131255000.0,"UnrealizedGainLossOnInvestments_4_FY_USD":-8000.0,"ShareBasedCompensation_4_FY_USD":3645000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":478000.0,"ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4_FY_USD":-44000.0,"StockIssuedDuringPeriodValueAcquisitions_4_FY_USD":95361000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.01,"RepaymentsOfNotesPayable_4_FY_USD":10293000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.01,"AccruedLiabilitiesCurrent_0_FY_USD":9703000.0,"CommitmentsAndContingencies_0_FY_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":3557065.0,"GeneralAndAdministrativeExpense_4_FY_USD":13265000.0,"ShortTermInvestments_0_FY_USD":81742000.0,"ClassOfWarrantOrRightOutstanding_0_FY_shares":498500.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":500000.0,"CashAcquiredFromAcquisition_4_FY_USD":29371000.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":5012000.0,"CommonStockValue_0_FY_USD":42000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_4_FY_USD":0.0,"LongTermNotesPayable_0_FY_USD":0.0,"DepreciationDepletionAndAmortization_4_FY_USD":239000.0,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":0.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_4_FY_USD":28304000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":101311000.0,"RealizedInvestmentGainsLosses_4_FY_USD":0.0,"DeferredTaxAssetsNet_0_FY_USD":118000.0,"InterestAndDebtExpense_4_FY_USD":508000.0,"CashCashEquivalentsAndShortTermInvestments_0_FY_USD":127600000.0,"ProceedsFromNotesPayable_4_FY_USD":1726000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-110715000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_4_FY_USD":-8000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-110723000.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":-426000.0,"OtherAssetsNoncurrent_0_FY_USD":857000.0,"Liabilities_0_FY_USD":11218000.0,"RestructuringAndRelatedCostExpectedCostRemaining1_0_FY_USD":0.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0_FY_USD":2037000.0,"DeferredIncomeTaxLiabilities_0_FY_USD":118000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":-0.009,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":2000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":258000.0,"CommonStockSharesAuthorized_0_FY_shares":100000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_4_FY_USD":0.0,"DeferredTaxAssetsGross_0_FY_USD":29191000.0,"CommonStockSharesOutstanding_0_FY_shares":4231135.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":81807000.0,"AmortizationOfFinancingCosts_4_FY_USD":281000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_4_FY_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":3443000.0,"OperatingLossCarryforwards_0_FY_USD":104100000.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":0.158,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":3645000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-29779000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_4_FY_USD":65990000.0,"LiabilitiesCurrent_0_FY_USD":10674000.0,"AccountsPayableCurrent_0_FY_USD":670000.0,"IncreaseDecreaseInAccountsReceivable_4_FY_USD":-99000.0,"NonoperatingIncomeExpense_4_FY_USD":173000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":1972000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":523000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"AdditionalPaidInCapital_0_FY_USD":218089000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_FY_USD":16.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_4_FY_USD":6000000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":26000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_4_FY_pure":-0.004,"NumberOfOperatingSegments_4_FY_segment":1.0,"UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_0_FY_USD":0.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_4_FY_USD":90997000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":309000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":45897000.0,"RestructuringAndRelatedCostCostIncurredToDate1_0_FY_USD":2400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":21051000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":494000.0,"OperatingIncomeLoss_4_FY_USD":-110380000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_FY_shares":4571288.0,"NotesPayableCurrent_0_FY_USD":0.0,"RestructuringReserve_0_FY_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_FY_USD":301000.0,"PreferredStockValue_0_FY_USD":0.0,"RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4_FY_pure":0.5,"LiabilitiesAndStockholdersEquity_0_FY_USD":131255000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":1963000.0,"PreferredStockSharesAuthorized_0_FY_shares":5000000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":3645000.0,"ProceedsFromIssuanceOfWarrants_4_FY_USD":25104000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":29073000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-278887000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":3752000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":455000.0,"OperatingExpenses_4_FY_USD":111430000.0,"DeferredTaxAssetsLiabilitiesNet_0_FY_USD":0.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-31.13,"OtherLiabilitiesNoncurrent_0_FY_USD":544000.0,"StockholdersEquity_0_FY_USD":120037000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":42000.0,"AccretionExpense_4_FY_USD":263000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":-56000.0,"AccruedRentCurrent_0_FY_USD":0.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":1571000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_4_FY_USD":1050000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_FY_shares":1033256.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.013,"AccruedProfessionalFeesCurrent_0_FY_USD":796000.0,"Ticker":"VRDN","CIK":"1590750","name":"VIRIDIAN THERAPEUTICS, INC.DE","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210326"}]